Leukemia (includes ALL, AML, APL, CLL, CML, MDS, Myeloproliferative Disorders, Myelofibrosis)
Featured Articles
(Penn LDI) Apr 18, 2018 - Spending on cancer drugs in the United States has nearly doubled in the past five years and continues to grow, imposing substantial financial burden on patients with cancer. One of the biggest drivers of this growth is targeted cancer drugs.
Read Article
(Washington Post/Wonkblog) Apr 18, 2018 - A group of cancer doctors focused on bringing down the cost of treatments by testing whether lower — and cheaper — doses are effective thought they had found a prime candidate in a blood cancer drug called Imbruvica that typically costs $148,000 a year.
Read Article
Latest Articles
April 23, 2018
April 20, 2018
April 20, 2018
April 19, 2018
April 17, 2018
April 16, 2018
April 16, 2018
April 10, 2018
View More
News Commentary
Editor Image
26 Apr, 2017 | by Howard S. Hochster, MD
Fascinating legal wrangling as the Supremes parse the wording of the BPCIA...
View Comment
View More
OBR Green
There are no Leukemia (includes ALL, AML, APL, CLL, CML, MDS, Myeloproliferative Disorders, Myelofibrosis) OBR Green articles.
OBR Blog
There are no Leukemia (includes ALL, AML, APL, CLL, CML, MDS, Myeloproliferative Disorders, Myelofibrosis) blog entries.